Williams and Fu
Page 3
versatility of these oxazole derivatives as coupling partners, and illustrates a general strategy
for the regioselective preparation of 2,4- and 2,5-disubstituted-1,3-oxazoles. These findings
provide for the incorporation of the intact oxazole heterocycle through bonding at C-4 or C-5
by using the phenylsulfonyl moiety as a blocking unit of the reactive C-2 position. Mild
conditions for reductive desulfonylation have been described. Applications for natural product
synthesis will be reported in due course.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We acknowledge the support of Indiana University and partial support of the National Institute of Health (GM 042897).
We acknowledge the assistance of Fese Mokube (Indiana University) for the preparation of vinyl stannane in Entry
3, Table 2.
References and Notes
1. Taylor, EC.; Wipf, P. Oxazoles: Synthesis, Reactions, And Spectrometry. John Wiley & Sons;
Hoboken: 2003.
2. For examples, see: (a) Ichiba T, Yoshida WY, Scheuer PJ, Higa T, Gravalos DG. J Am Chem Soc
1991;113:3173. (b) Shin-ya K, Wierzba K, Matsuo K, Ohtani T, Yamada Y, Furihata K, Hayakawa
Y, Seto H. J Am Chem Soc 2001;123:1262. [PubMed: 11456694] (c) Searle PA, Molinski TF. J Am
Chem Soc 1995;117:8126. (d) Rosener JA, Scheuer PJ. J Am Chem Soc 1986;108:846. (e) Dalisay
DS, Rogers EW, Edison AS, Molinski TF. J Nat Prod 2009;72:732. [PubMed: 19254038] (f) Li J,
Burgett AWG, Esser L, Amezcua C, Harran PG. Angew Chem Int Ed 2001;40:4770. (g) Irschik H,
Jansen R, Gerth K. J Antibiot 1995;48:31. [PubMed: 7868386]
3. For examples, see: (a) Kanoh K, Matsuo Y, Adachi K, Imagawa H, Nishizawa M, Shizuri Y. J Antibiot
2005;58:289. [PubMed: 15981418] (b) Perez LJ, Faulkner DJ. J Nat Prod 2003;66:247. [PubMed:
12608858] (c) Kohno J, Kameda N, Nisho M, Kinumaki A, Komatsubara S. J Antibiot 1996;49:1063.
[PubMed: 8968404]
4. Phillips AJ, Uto Y, Wipf P, Reno MJ, Williams DR. Org Lett 2000;2:1165. [PubMed: 10804580] (b)
For the initial application of this methodology in the synthesis of hennoxazole A, see: Williams DR,
Brooks DA, Berliner MA. J Am Chem Soc 1999;121:1303. (c) Wipf P, Rahman LT, Rector SR. J Org
Chem 1998;63:7132. [PubMed: 11672349] (d) Wipf P, Miller CP. J Org Chem 1993;58:3604.
5. (a) Besselièvre F, Piguel S, Mahuteau-Betzer F, Grierson DS. Org Lett 2008;10:4029. [PubMed:
18720988] (b) Flegeau EF, Popkin ME, Greaney MF. Org Lett 2008;10:2717. [PubMed: 18540631]
(c) Hodgetts KJ, Kershaw MT. Org Lett 2002;4:2905. [PubMed: 12182585] (d) Smith AB III, Minbiole
KP, Freeze S. Synlett 2001:1739.
6. Hämmerle J, Spina M, Schnürch M, Mihovilovic MD, Stanetty P. Synthesis 2008:3099.
7. Lee K, Counceller CM, Stambuli JP. Org Lett 2009;11:1457. [PubMed: 19239243]
8. Shafer CM, Molinski TF. J Org Chem 1998;65:551. [PubMed: 11672044]
9. Marino JP, Nguyn HN. Tetrahedron Lett 2003;44:7395.
10. Phillips JG, Fadnis L, Williams DR. Tetrahedron Lett 1997;38:7835.
11. Williams DR, Fu L. Org Lett 2010;12:808. [PubMed: 20085311]
12. (a) For the initial report of the halogen dance isomerization of 5-bromo-2-phenyl-1,3-oxazole:
Stanetty P, Spina M, Mihovilovic MD. Synlett 2005:1433. (b) Iso Y, Shindo H, Hamana H.
Tetrahedron 2000;56:5353. (c) Kashima C, Arao H. Synthesis 1998:873.
13. Williams DR, Fu L. Synlett 2010:591.
Synlett. Author manuscript; available in PMC 2011 July 1.